Onconic Therapeutics온코닉테라퓨틱스
476060 · KOSDAQ · ₩476060 · 온코닉테라퓨틱스
Technical gauge
After the close on Oct 27, 2026Short term
Bearish
0 bullish, 1 neutral, 8 bearish
Medium term
Bearish
0 bullish, 1 neutral, 7 bearish
What the indicators say
Onconic Therapeutics closed at 12,940 won, below all of its key moving averages, with the 5-day average at 13,446 won, the 20-day at 14,481 won, the 60-day at 14,461.8 won, the 120-day at 15,417.1 won and the 200-day at 17,608.2 won. Short-term and medium-term gauges both read bearish, with MACD at -512.7 below its signal line of -339.2 and the ADX at 19.3 indicating a weak trend, while the stochastic %K of 19.7 and RSI of 37.4 sit in lower territory. Volume is running at 0.6 times its 20-day average and OBV is trending down, and the stock is trading below the Ichimoku cloud. Traders usually watch the support at 12,550 won and the resistance at 15,150 won, and the price remains about 89 percent below its 20-day and 60-day disparity readings of 89.4 and 89.5 relative to those averages.
Written by AI from the indicator values above. Not advice.
Technical indicators describe past price and volume patterns. They are not predictions or recommendations.
Squeeze! setup
1D timeframeNo squeeze setup on this stock right now.
Chart
2026-10-27O 12,700H 13,150L 12,700C 12,770
Every indicator, chart overlays and the stock's recent technical events, with Pro.Unlock with Pro →
Indicators
- Moving averagesPrice above 0 of 5 averages5d ₩12,980 · 20d ₩14,244 · 60d ₩14,524 · 120d ₩15,252 · 200d ₩17,513Price above its averages is commonly read as an uptrend, below as a downtrend; the 200-day line is widely watched for the long-term trend.
- RSI (14)Downward momentum38.3Measures the speed of recent gains vs losses. Above 70 is often called overbought, below 30 oversold; extremes can last in strong trends.
- MACD (12, 26, 9)Below its signal line-612 · signal -434 · histogram -178The gap between 12- and 26-day exponential averages. Crossing its signal line is read as momentum turning; above zero, the short-term average is above the long.
- Bollinger Bands (20, 2)Inside the bands₩11,931 – ₩14,244 – ₩16,557 · width 32.5%Bands two standard deviations around the 20-day average. A squeeze (very narrow bands) means unusually quiet trading, which often comes before a bigger move either way.
- Volume vs 20-day averageNormal trading0.64×Trading volume compared with its 20-day average. Moves on heavy volume are usually given more weight.
Every indicator, chart overlays and the stock's recent technical events, with Pro.
Unlock with ProTechnical events, last 90 days
Every indicator, chart overlays and the stock's recent technical events, with Pro.
Unlock with ProShort squeeze tracker
Score hidden
Sign in free to track one stock with the full squeeze tracker.
See the short squeeze score on your watchlist stocks with Pro.Unlock with Pro →or add Squeeze Pro (US$49/month) →
Estimates from short-selling data. Levels are not predictions or trading recommendations.
Share lending and returned shares
Shares lent out (mostly to short sellers), new loans and shares returned each day. A return is either the lender calling the shares back (a recall) or the borrower handing them back, often after buying back a short. The published figures don't say which.
- Shares on loan
- 2.1M
- 4.6% of listed shares
- Loans, 5-day change
- +8.6%
- Loans, 20-day change
- +8.7%
- Returned, last 5 days
- 115.9K
- New loans, last 5 days
- 280.8K
- Short balance vs loans
- 30.7%
- How much of the lent stock is sold short. The higher it is, the more buying back a wave of recalls forces.
Who's borrowing: foreign vs domestic
The shares on loan by who borrowed them and who lent them, by value.
- Foreign share, 5 days
- —
- Foreign share, 20 days
- —
- Foreign borrowing, 5 days
- —
As of Oct 27. Domestic borrowers include Korean brokers, some of which borrow for overseas clients, so this shows who holds the loan, not who finally sells short. Not a recommendation.
Unusual return days (last 60 days)
| Day | Returned | Of the loans | Vs usual |
|---|---|---|---|
| Oct 26 | 78.8K | 3.8% | 3× |
| Oct 19 | 138.9K | 7.4% | 7× |
| Sep 28 | 58.3K | 3.1% | 3.3× |
| Sep 14 | 56.6K | 3% | 3× |
| Sep 10 | 73.6K | 3.8% | 4.8× |
| Aug 24 | 62.2K | 3.3% | 3× |
| Aug 18 | 71.8K | 3.8% | 3.2× |
Unusual = at least 3× the 20-day average, at least 2% of the shares on loan and 10,000 shares.
As of Oct 27. Published figures, one trading day behind. They describe lending, not where the price goes; not a recommendation.
Lending data: Financial Services Commission, Korea (Public Data Portal).
Retail margin & forced selling
Margin loans
₩30T
−7.3% in 5 days · 8th percentile of the last year
Forced selling
₩11B
0.4× the 20-day average
Forced-sale share
1.0%
Unpaid settlements
₩1T
Retail stock borrowing ₩21B
Calm under 30, normal to 50, elevated to 70, high above. From today's forced-sale amount vs its 20-day average, the forced-sale share of receivables, where margin loans sit in their 1-year range, and whether they are being cut fast.
Estimates from public margin-lending statistics. Not a prediction or a recommendation.
Technical indicators describe past price and volume patterns. They are not predictions or recommendations.
Also known as: Onconic Therapeutics / 온코닉테라퓨틱스 / 476060 / KRX:476060
Source: KRX statistical information